Drugs.com - FDA MedWatch Alerts

Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles

Audience: Healthcare Provider, Pharmacy October 16, 2024 -- Bennet, NE -- STASKA PHARMACEUTICALS, INC. is voluntarily recalling 1 lot of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL, 50mL vials to the user level. This...

Feb 9, 2025 - 21:44
 0
Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles
Audience: Healthcare Provider, Pharmacy October 16, 2024 -- Bennet, NE -- STASKA PHARMACEUTICALS, INC. is voluntarily recalling 1 lot of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL, 50mL vials to the user level. This...
Read More

Tags:

Previous Article

C&A Naturistics Issues Voluntary Nationwide Recall of AK Forte Tablets con Ortig...

Next Article

FDA is Alerting Patients and Health Care Professionals About the Voluntary Withd...

Related Posts

Public Safety Notification on Amniotic Fluid Eyedrops

Public Safety Notification on Amniotic Fluid Eyedrops

Feb 9, 2025  0

Alcon Laboratories Issues Voluntary Nationwide Recall of One Lot of Systane Lubricant Eye Drops Ultra PF Due to Fungal Contamination

Alcon Laboratories Issues Voluntary Nationwide Recall o...

Feb 9, 2025  0

FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (elivaldogene autotemcel)

FDA Investigating Serious Risk of Hematologic Malignanc...

Feb 9, 2025  0